Participants
Contact
Biocat, the organization that coordinates and promotes the biotechnology, biomedical and medical technology sectors in Catalonia, the BioRegion of Catalonia, reports on the European project Nabarsi, which sees the collaboration of the IRB Barcelona spin off Omnia Molecular. The company, developed by Lluís Ribas de Pouplana, ICREA researcher at IRB, will have a key role in this three-year EU project.
Read the news in Biocat (PDF)
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
